Lianne C. Krab on Muck Rack

Lianne C. Krab

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lianne C.

Contact Lianne C., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders

|
By Myrthe J. Ottenhoff, Lianne C. Krab, Amsterdam UMC, Ype Elgersma
| eneuro.org
Commentary, Disorders of the Nervous System Myrthe J. Ottenhoff, Lianne C.
Open in Who Shared Issue with article?

Considerations for clinical therapeutic development of statins for neurodevelopmental disorders

|
By Amsterdam UMC, Myrthe J. Ottenhoff, Lianne C. Krab, Ype Elgersma
| eneuro.org
Commentary, Disorders of the Nervous System Myrthe J. Ottenhoff, Lianne C. Krab and Ype Elgersma eNeuro 18 February 2020, ENEURO.0392-19.2020; DOI: https://doi.org/10.1523/ENEURO.0392-19.2020 Abstract Significance statement The HMG-CoA reductase inhibitors lovastatin and simvastatin have both been investigated in clinical trials designed to treat the cognitive deficits associated with neurodevelopmental disorders such as Neurofibromatosis type 1, Fragile X and autism.
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified